Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England
Gout is caused by urate crystal deposition secondary to persistent hyperuricemia. Current guidelines recommend urate-lowering treatment to prevent crystal deposition and encourage crystal dissolution for patients with more severe gout or concomitant conditions.1,2 However, after the first diagnosis,...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
American Medical Association
2014
|
| Online Access: | https://eprints.nottingham.ac.uk/35899/ |